Proteomics in Kidney Allograft Transplantation—Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection
暂无分享,去创建一个
H. Husi | W. Mullen | D. Marx | J. Metzger | W. Gwinner | S. Faguer | S. Caillard | M. Colombat | J. Olagne | Iwona Belczacka
[1] H. Jeong. Diagnosis of renal transplant rejection: Banff classification and beyond , 2020, Kidney research and clinical practice.
[2] L. Pieroni,et al. Urinary Peptidomic Biomarkers in Kidney Diseases , 2019, International journal of molecular sciences.
[3] G. Reusz. Urinary proteomics: fancy gadgetry or a clinically useful diagnostic instrument? The end‐user's perspective , 2019, Transplant international : official journal of the European Society for Organ Transplantation.
[4] Arkaitz Carracedo,et al. Rewiring urea cycle metabolism in cancer to support anabolism , 2018, Nature Reviews Cancer.
[5] L. Jia,et al. Identification of potential key protein interaction networks of BK virus nephropathy in patients receiving kidney transplantation , 2018, Scientific Reports.
[6] Z. Abedin,et al. Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation , 2018, Transplantation direct.
[7] M. Stegall,et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] P. Halloran,et al. Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes. , 2017, JCI insight.
[9] D. Nieboer,et al. MicroRNAs Differentiate Between Antibody and T-Cell Mediated Renal Allograft Rejection , 2017 .
[10] Y. Omidi,et al. Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function , 2017, International Urology and Nephrology.
[11] Li Li,et al. Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach , 2017, Scientific Reports.
[12] T. Muthukumar,et al. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] G. Mazzucco,et al. Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] D. San Segundo,et al. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies? , 2016, Transplantation proceedings.
[15] N. Salomonis,et al. Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy , 2016, Transplantation.
[16] Yi Luan,et al. Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study , 2016, The Lancet.
[17] A. Su,et al. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long‐Term Outcomes , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] E. Conway,et al. Cross Talk Pathways Between Coagulation and Inflammation. , 2016, Circulation research.
[19] H. Husi,et al. Proteomics for rejection diagnosis in renal transplant patients: Where are we now? , 2016, World journal of transplantation.
[20] K. Famulski,et al. The Molecular Landscape of Antibody‐Mediated Kidney Transplant Rejection: Evidence for NK Involvement Through CD16a Fc Receptors , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] M. Mengel,et al. The significance of histological diagnosis in renal allograft biopsies in 2014 , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[22] K. Famulski,et al. Molecular Landscape of T Cell–Mediated Rejection in Human Kidney Transplants: Prominence of CTLA4 and PD Ligands , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] J. Chapman,et al. The Role of Macrophages in the Development of Human Renal Allograft Fibrosis in the First Year After Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] Pilib Ó Broin,et al. Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies. , 2014, Kidney international.
[25] W. Kolch,et al. HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. , 2014, Journal of proteome research.
[26] D. Rush,et al. Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] Ronald J. Moore,et al. The Identification of Novel Potential Injury Mechanisms and Candidate Biomarkers in Renal Allograft Rejection by Quantitative Proteomics* , 2013, Molecular & Cellular Proteomics.
[28] A. McKnight,et al. Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes , 2013, PloS one.
[29] S. Head,et al. Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury , 2013, BMC Genomics.
[30] L. Racusen,et al. The Banff classification revisited. , 2013, Kidney international.
[31] M. Scian,et al. MicroRNAs as Biomarkers in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] R. Cavallo,et al. Polyomavirus-associated nephropathy. , 2012, World journal of transplantation.
[33] Raymond Vanholder,et al. Implementation of proteomic biomarkers: making it work , 2012, European journal of clinical investigation.
[34] A. Åsberg,et al. Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients , 2012, Transplantation research.
[35] R. Colvin,et al. Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[36] J. Cheeseman,et al. Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[37] Matko Bosnjak,et al. REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.
[38] H. Mischak,et al. Diagnosis of subclinical and clinical acute T‐cell‐mediated rejection in renal transplant patients by urinary proteome analysis , 2011, Proteomics. Clinical applications.
[39] D. Muruve,et al. Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection , 2010, Transplantation.
[40] H. Mischak,et al. Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. , 2010, Kidney international.
[41] M. Sarwal,et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. , 2010, Journal of the American Society of Nephrology : JASN.
[42] J. Yates,et al. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. , 2010, Journal of the American Society of Nephrology : JASN.
[43] David G Camp,et al. Shotgun proteomics identifies proteins specific for acute renal transplant rejection , 2010, Proteomics. Clinical applications.
[44] T. Kelley,et al. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway , 2009, BMC Immunology.
[45] Rachael P. Huntley,et al. QuickGO: a web-based tool for Gene Ontology searching , 2009, Bioinform..
[46] J. Szustakowski,et al. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[47] A. Kiss,et al. Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation? , 2009, Journal of cellular and molecular medicine.
[48] P. Nickerson,et al. Proteomic portrayal of transplant pathologies. , 2009, Journal of the American Society of Nephrology : JASN.
[49] M. Hattori,et al. Caveolin‐1 Expression Is a Distinct Feature of Chronic Rejection‐Induced Transplant Capillaropathy , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[50] Chris Mungall,et al. AmiGO: online access to ontology and annotation data , 2008, Bioinform..
[51] R. Colvin,et al. Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[52] P. Tipping,et al. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. , 2005, Journal of the American Society of Nephrology : JASN.
[53] H. Mischak,et al. Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use , 2004, Electrophoresis.
[54] Timo Paavonen,et al. International Variation in Histologic Grading Is Large, and Persistent Feedback Does Not Improve Reproducibility , 2003, The American journal of surgical pathology.
[55] P. Nickerson,et al. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[56] C. Hack,et al. Apoptosis induced by granzyme B-glycosaminoglycan complexes: implications for granule-mediated apoptosis in vivo. , 1999, Journal of immunology.
[57] J F Burdick,et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. , 1993, Kidney international.
[58] K. Shah,et al. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. , 1973, The Journal of infectious diseases.
[59] C. Cohen,et al. Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy. , 2012, Kidney international.
[60] A. Djamali,et al. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. , 2008, Transplantation reviews.
[61] I. T. Ten Berge,et al. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. , 1995, Kidney international.